RAPT

Rapt Therapeutics INC

+$585.7M

Net Activity

Institutions Holding

104

Popularity Rank

#4308

Avg Weight

0.62%

Total Value

$943.7M

Ownership Trend

104 institutions currently hold RAPT, with 86 net buyers and 16 net sellers this quarter.

Institutional Moves

Institutional Moves (Q4 2025)

Significantly Increased

Based on recent trading activity

Net Selling Institutions

16

Net Buying Institutions

86

Key Holders

View all 104 holding institutions

Quarterly Activity

Recent Activity

+$865.1M

Total Buy Value

$47.8M

Total Sell Value

New buy50
Trim8
Add36
Sold out8

86

Net Buyers

16

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding RAPT THERAPEUTICS INC (RAPT)?
Major stakeholders currently include TCG Crossover Management, LLC ($87.5M), Fcpm Iii Services B.v. ($62.1M), Orbimed Advisors LLC ($55.6M). Based on the latest 13F filings, there are a total of 104 tracked investment funds and institutions maintaining positions in RAPT.
What is the overall institutional sentiment toward RAPT recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $585.7M, driven by 86 managers accumulating shares while 16 reduced their exposure.
Which institutions have been selling or reducing their RAPT positions?
In the latest period, 8 funds trimmed their holdings, and 8 managers completely exited their positions. The aggregate reported sell value was $47.8M.
Are there any notable investors adding RAPT to their portfolios?
Yes, buying activity remains notable. 50 institutions opened new positions in {ticker}, and 36 existing holders added to their shares. The total reported buy value for the quarter amounted to $865.1M.

Related Stocks